FIELD: biotechnology.
SUBSTANCE: genetic material is delivered to the eukaryotic cells by binding the plasmid DNA in a complex with the recombinant H2A or H2A-TAT histone in the presence of a biodegradable lipide represented by choline fatty acid ester.
EFFECT: compared with non-viral analogs, the invention allows to deliver the genetic material to eukaryotic cells of interest more efficiently.
12 cl, 6 dwg, 10 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MULTIPURPOSE CANCER-SPECIFIC PROMOTERS AND USING THEM IN ANTI-CANCER THERAPY | 2013 |
|
RU2539764C2 |
| METHOD OF PRODUCING PLASMID DNA IN POLYMER NANOSPHERES FOR DELIVERY | 2022 |
|
RU2817116C1 |
| ISOLATED KillerRed PROTEIN-CODING NUCLEIC ACID (VERSIONS), ISOLATED PROTEIN (VERSIONS), EXPRESSION CASSETTE, CELL CONTAINING EXPRESSION CASSETTE | 2011 |
|
RU2458129C1 |
| MULTI-PURPOSE PROMOTER, EXPRESSION VECTOR, AND METHOD OF SELECTIVE KILLING CANCER CELLS WITH THEIR USE | 2012 |
|
RU2476596C1 |
| ISOLATED NUCLEIC ACID, ENCODING OPERATIVELY FUSED INTRAMOLECULAR DIMER OF KillerRed PROTEIN, EXPRESSION CASSETTE, CELL, WHICH PRODUCES CHIMERIC PROTEIN AND CONTAINS EXPRESSION CASSETTE, ISOLATED CHIMERIC PROTEIN | 2011 |
|
RU2491342C1 |
| GENE THERAPY PREPARATION FCU1-BSFM/PP FOR TREATING SOLID TUMOURS | 2023 |
|
RU2824977C1 |
| DRUG COMBINATION FOR GENE-IMMUNE THERAPY | 2022 |
|
RU2792683C1 |
| METHOD OF DELIVERY OF NUCLEINIC ACIDS INTO EUKARYOTIC CELLS | 2014 |
|
RU2563804C1 |
| IMMORTALISED CELL LINE OF BIRDS | 2008 |
|
RU2475536C2 |
| PHARMACOLOGICAL COMBINATION OF POLYCATIONIC CARRIER PEG-PEI-TAT WITH INCLUDED IN IT PLASMID CARRYING THERAPEUTIC GENES HSVtk AND GM-CSF FOR GENE THERAPY OF TUMOROUS DISEASES | 2013 |
|
RU2575077C2 |
